Clinical Trial Update: Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1 [NA]

View source ↗

Summary

This clinical trial update reports on neuropsychological impairment and quality of life in Neurofibromatosis Type 1.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurofibromatosis Type

Snippet

Sponsor: Nantes University Hospital | Conditions: Neurofibromatosis Type 1 | NA | Status: COMPLETED